338 results on '"Thuret, Isabelle"'
Search Results
52. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome
53. Persistence of natural killer cells with expansion of a hypofunctional CD56−CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3–deficient severe combined immunodeficiency
54. Treatment interruption for virological failure or as sparing regimen in children with chronic HIV-1 infection
55. Outcome in Children With Relapsed Acute Myeloid Leukemia After Initial Treatment With the French Leucémie Aiquë Myéloïde Enfant (LAME) 89/91 Protocol of the French Society of Pediatric Hematology and Immunology
56. Histopathology of the liver in adolescents co-infected with HIV and hepatitis C virus
57. Impact of Addition of Maintenance Therapy to Intensive Induction and Consolidation Chemotherapy for Childhood Acute Myeloblastic Leukemia: Results of a Prospective Randomized Trial, LAME 89/91
58. 28 - Efficacy and Safety of Betibeglogene Autotemcel (beti-cel) Gene Therapy in 63 Patients with Transfusion-Dependent β-Thalassemia (TDT): 7-Year Post-Infusion Follow-up of Phase 1/2 and Phase 3 Studies
59. Northstar-3: Interim Results from a Phase 3 Study Evaluating Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Either a β0 or IVS-I-110 Mutation at Both Alleles of the HBB Gene
60. Stenosis Outcome at 1 and 3 Years after Transplantation Vs Standard-Care in Children with Sickle-Cell Anemia and Abnormal Transcranial Doppler with Stroke or No-Stroke History
61. Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Non-β0/β0 Genotypes
62. Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed By Newborn Screening: A Real-World Nation-Wide Study in France
63. Genotype/phenotype correlations of childhood‐onset congenital sideroblastic anaemia in a European cohort
64. Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency
65. Transfusion transmitted virus
66. Improved stenosis outcome in stroke‐free sickle cell anemia children after transplantation compared to chronic transfusion.
67. 1 - Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion
68. Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study
69. Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients
70. Sustainability of Hematological and Clinical Benefits to HU Administration in the Prevention of Sickle-Cell Vaso-Occlusive Crises in Routine Practice
71. Lentiglobin Gene Therapy for Patients with Transfusion-Dependent β-Thalassemia (TDT): Results from the Phase 3 Northstar-2 and Northstar-3 Studies
72. Probability of TCD-Normalization in the "Drepagreffe" Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels
73. Towards Mechanical Clinical Markers in Sickle Cell Disease: Dynamics of Red Blood Cells in Low Shear Flow
74. Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience
75. Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)
76. Marseillevirus prevalence in multitransfused patients suggests blood transmission
77. Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
78. French National Drepagreffe Trial: Cognitive Performances and Neuroimaging at Enrollment and after 12 Months on Transfusion Program or Transplantation (AP-HP: NCT 01340404)
79. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island
80. Health-Related Quality of Life at 1 Year in the Drepagreffe Trial Comparing Chronic Transfusion to Transplantation in Children with Sickle Cell Anemia and a History of Abnormal Cerebral Velocities
81. Results from the Hgb-207 (Northstar-2) Trial: A Phase 3 Study to Evaluate Safety and Efficacy of Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia (TDT) in Patients with Non-β0/β0 Genotypes
82. Response of Patients with Transfusion-Dependent β-Thalassemia (TDT) to Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-Thalassemia) Gene Therapy Based on HBBGenotype and Disease Genetic Modifiers
83. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
84. Cerebral Arterial Velocities in SCA-Children with Abnormal Doppler Are Reduced and Normalized More Frequently after Transplantation Than after Transfusion Program (French National Trial “Drepagreffe” AP-HP N°: NCT 01340404)
85. Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC
86. Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era?
87. Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results
88. Traitement des surcharges en fer post-transfusionnelles par le déférasirox
89. Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results
90. Surcharges en fer post-transfusionnelles : comment optimiser la prise en charge du patient ?
91. VERTICAL TRANSMISSION OF MULTIDRUG-RESISTANT Q151M HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 STRAINS
92. Socio-Economic Impact of Infused Iron Chelation Therapy in France: ISOSFER Study Results.
93. Expression of Granzyme B in viral hepatitis in patients with ALPS
94. Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants
95. Hb AUBAGNE [β64(E8)Gly→Ala]: A NEW UNSTABLEβCHAIN VARIANT FOUND IN A FRENCH FAMILY
96. Patterns of mortality in sickle cell disease in adults in France and England
97. Relationship Between Efficacy, Tolerance, and Plasma Drug Concentration of Ritonavir in Children With Advanced HIV Infection
98. Les syndromes thalassémiques
99. Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population
100. Ischemic Cerebrovascular Disease in Children: Retrospective Study of 35 Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.